Geraldine Laven‐Law

The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

Theresa E. Hickey, Luke A. Selth, Kee Ming Chia et al. · Nature Medicine · 2021 · 254 citations · Full text

Medicine, Cancer Biology, Oncology +14

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent

Abiodun D. Ogunniyi, Manouchehr Khazandi, Andrew J. Stevens et al. · PLoS ONE · 2017 · 76 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Non-canonical AR activity facilitates endocrine resistance in breast cancer

Heloisa Milioli, Neil Portman, Geraldine Laven‐Law et al. · Endocrine Related Cancer · 2018 · 47 citations · Full text

Medicine, Oncology, Pharmacology +11

The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer

Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman et al. · Nature Structural & Molecular Biology · 2024 · 31 citations · Full text

Life Sciences, Genetics, Oncology +15

Androgen Receptor Signalling Promotes a Luminal Phenotype in Mammary Epithelial Cells

Gerard A. Tarulli, Geraldine Laven‐Law, Mona Shehata et al. · Journal of Mammary Gland Biology and Neoplasia · 2018 · 24 citations

Life Sciences, Biochemistry, Endocrinology +16